Hoxton Planning & Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$730K Sell
2,875
-378
-12% -$88.1K 0.19% 89
2026
Q1
$795K Buy
3,253
+356
+12% +$82.9K 0.24% 70
2025
Q4
$600K Sell
2,897
-13
-0.4% -$2.57K 0.18% 98
2025
Q3
$540K Sell
2,910
-347
-11% -$59.5K 0.17% 107
2025
Q2
$498K Sell
3,257
-17
-0.5% -$2.61K 0.17% 108
2025
Q1
$543K Buy
3,274
+114
+4% +$17.8K 0.21% 96
2024
Q4
$457K Sell
3,160
-301
-9% -$46.6K 0.17% 111
2024
Q3
$561K Buy
3,461
+969
+39% +$154K 0.22% 91
2024
Q2
$364K Sell
2,492
-1,054
-30% -$157K 0.17% 103
2024
Q1
$561K Sell
3,546
-141
-4% -$22.4K 0.27% 74
2023
Q4
$578K Sell
3,687
-414
-10% -$63.5K 0.31% 60
2023
Q3
$639K Sell
4,101
-90
-2% -$14.9K 0.41% 49
2023
Q2
$694K Buy
4,191
+203
+5% +$32.8K 0.43% 41
2023
Q1
$618K Sell
3,988
-486
-11% -$78.5K 0.34% 57
2022
Q4
$790K Buy
+4,474
New +$773K 0.42% 42

Other funds holding JNJ

Hoxton Planning & Management's JNJ Position: Q2 2026 in Review

Hoxton Planning & Management reduced its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, selling an estimated $88.1K and leaving 2,875 shares worth $730K. The position accounts for 0.19% of the portfolio, ranked #89.

Hoxton Planning & Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $795K in Q1 2026. 1,133 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hoxton Planning & Management held 2,875 shares of Johnson & Johnson worth $730K as of Q2 2026.
  • Hoxton Planning & Management sold 378 Johnson & Johnson shares in Q2 2026, an estimated $88.1K.
  • Johnson & Johnson made up 0.19% of Hoxton Planning & Management's portfolio in Q2 2026, its #89 holding.
  • Hoxton Planning & Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Hoxton Planning & Management's Johnson & Johnson position peaked at $795K in Q1 2026.
  • 1,133 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hoxton Planning & Management's 13F filing for Q2 2026, filed 16 Jul 2026.